Kazatomprom Reports 17 Production Surge in Third Quarter Highlighting Operational Strength US Consumer Prices Rise 38 Annually in April Topping Expectations Spotify Soars After AI Music Deal With Universal Music Group and LongTerm Guidance Novartis Upgrades FullYear Outlook on Strong Portfolio Momentum BofA Advises Ignoring Market Noise on NVIDIA NVDA Focus on Fundamentals Forum Energy Technologies FET Reports 8 Revenue Growth in Q1 Fueled by International Demand SEZL Q1 2026 Earnings EPS Beats Estimates by 1658 as Stock Edges Lower SPRY Q1 2026 Earnings EPS Miss and PreRevenue Status Weigh on Shares as Neffy Launch Awaited Presurance Holdings Q1 2024 Earnings Surprise Profit Beats Estimates But Shares Slide on Revenue Disclosures Accelerant Holdings ARX Q1 2026 Earnings EPS Surpasses Estimates by 69 Stock Gains 15 COCO Q1 2026 Earnings Major EPS Beat Drives Optimism Despite Stock Decline AQNB Q1 2026 Earnings FixedtoFloating Note Delivers EPS Beat Amid Stable Utility Operations Helport AI Warrants HPAIW Slip 125 as Price Tests Critical Support at 004 QXO Inc QXO Edges Higher as Stock Tests Key Resistance Zone American Outdoor Brands AOUT Slides 125 as Stock Tests Key Support Levels FTC Solar Inc FTCI Climbs 25 as Stock Finds Support Near 464 DRDGOLD DRD Slips 4 as Gold Pullback Tests Key Support at 2481 Tony Wang T Rowe Price Manager Looks to AI Bottlenecks and Space Opportunities Simpson Manufacturing Q1 2026 Earnings EPS Beats Estimates by 1285 as Profitability Holds Firm Tenax Therapeutics TENX Faces Resistance Test After 186 Pullback From Recent Highs NovoCure NVCR Slumps 59 Testing Key Support at 1633 FG Stock Holds Near Support Amid Quiet Trading Session Cohen Steers Quality Income Realty Fund RQI Shows Modest Decline Amid Steady Income Focus Midland States Bancorp Preferred Shares MSBIP Hold Steady at 2543 Amidst Stability Pyrophyte Acquisition Corp II PAII Edges Higher by 020 as SPAC Trades Near Trust Value Park National Corporation PRK Holds Steady Above Key Support Resistance in View Compugen Surges 7 as Biotech Stock Tests Key Resistance Levels CGEN